Intercept Pharma up 9% premarket on rumors of potential Shire bid

|About: Intercept Pharmaceutic... (ICPT)|By:, SA News Editor

Intercept Pharmaceuticals (NASDAQ:ICPT) is up 9% premarket on light volume, apparently stoked by rumors of a possible bid by Shire plc (NASDAQ:SHPG).

Shire is supposedly close to a deal to acquire Baxalta (BXLT) for at least $30B in cash and stock. It recently bought (NASDAQ:DYAX) for $5.9B.

Previously: Bloomberg: Shire and Baxalta getting closer to deal (Dec. 11)

Previously: Shire buys Dyax for $5.9B in cash (Nov. 2)

Subscribe for full text news in your inbox